Re-evaluation of toxicity and long-term follow-up of isolated lung perfusion with melphalan in patients with resectable pulmonary metastases: a phase I and extension trial

Ann Thorac Surg. 2007 Mar;83(3):1235-6. doi: 10.1016/j.athoracsur.2006.09.061.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Chemotherapy, Cancer, Regional Perfusion*
  • Humans
  • Hyperthermia, Induced
  • Longitudinal Studies
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary*
  • Lung Neoplasms / surgery
  • Melphalan / administration & dosage
  • Melphalan / adverse effects*
  • Preoperative Care

Substances

  • Antineoplastic Agents, Alkylating
  • Melphalan